financial statements 129 Hikma PHarmaceuticals Plc annual report 2011 28. obligations under finance leases minimum present value of minimum lease payments lease payments 2011 2010 2011 2010 $000 $000 $000 $000 Amounts payable under finance leases: within one year 3,490 2,403 3,300 2,251 in two to five years inclusive 19,315 6,358 18,134 6,118 22,805 8,761 21,434 8,369 less: interest lease charges 1,371 392 present value of minimum lease payments payable 21,434 8,369 it is the Groups policy to lease certain of its property, plant and equipment under finance leases.
the average lease term is five years 2010: four years.
for the year ended 31 December 2011, the average effective borrowings rate was between 1.7% and 8.8% 2010: between 1.8% and 12%.
29. financial policies for risk management and their objectives credit and concentration of risk the Groups principal financial assets are cash and cash equivalents, trade and other receivables, and investments.
the Groups credit risk is primarily attributable to its trade receivables.
the amounts presented in the balance sheet are net of allowances for doubtful debts, chargebacks, without recourse discounts, and other allowances.
a provision for impairment is made where there is an identified loss event which, based on previous experience, is evidence of a reduction in the recoverability of the cash flows.
the credit risk on liquid funds and derivative financial instruments is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies.
in line with local market practice, customers in the mena region are offered relatively longer payment terms compared to customers ineurope and the us.
During the year ended 31 December 2011, the Groups largest three customers in the mena region represented 15.7% ofGroup revenue, 11.1% in saudi arabia, 2.7% in algeria and 1.9% in tunisia.
During the year ended 31 December 2011 and due to revenue growth in the us through the acquisition of msi, three key us wholesalers represented 18.8% of group revenues 2010: 12.1%.
the amount of receivables due from us customers at 31 December 2011 is usD 86,476,000 2010: usD 31,326,000. the Group manages this risk through the implementation of stringent credit policies, procedures and certain credit insurance agreements.
trade receivable exposures are managed locally in the operating units where they arise.
credit limits are set as deemed appropriate for the customer, based on a number of qualitative and quantitative factors related to the credit worthiness of a particular customer.
the Group is exposed to a variety of customers ranging from government backed agencies and large private wholesalers to privately owned pharmacies, and the underlying local economic risks vary across the Group.
typical credit terms in the us range from 3090 days, in europe 30120 days, and mena 180360 days.
Where appropriate, the Group endeavours to minimise risks by the use of trade finance instruments such as letters of creditand insurance.
market risk the Groups objective is to reduce, where it is deemed appropriate to do so, fluctuations in earnings and cash flow associated with changes in interest rates and foreign currency rates.
the Group is exposed to foreign exchange and interest rate risk.
management actively monitors these exposures to manage the volatility relating to these exposures by entering into a variety of derivative financial instruments.
capital risk management the Group manages its capital and monitors its liquidity to have reasonable assurance that the Group will be able to continue as a going concern and deliver its growth strategy objectives whilst reducing its cost of capital and maximising the returns to shareholders through the optimisation of the debt and equity mix.
the Group regularly reviews the capital structure by considering the level of available capital and the short to medium-term strategic plans concerning future capital spend as well as the need to meet dividends, banking covenants and borrowing ratios.
